Photo by kommumikation from unsplash
There are no randomized trials comparing bivalirudin with heparin in patients undergoing peripheral vascular intervention. Retrospective analyses suggest that bivalirudin treatment during peripheral vascular intervention is associated with less bleeding… Click to show full abstract
There are no randomized trials comparing bivalirudin with heparin in patients undergoing peripheral vascular intervention. Retrospective analyses suggest that bivalirudin treatment during peripheral vascular intervention is associated with less bleeding and a reduction in major adverse clinical events. Despite a higher acquisition cost compared with heparin, bivalirudin may actually provide more value and possibly reduce the total cost of care associated with peripheral interventions.
Journal Title: Catheterization and Cardiovascular Interventions
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!